CochLear Valuation
| CHEOY Stock | USD 99.89 0.45 0.45% |
At this time, the firm appears to be fairly valued. CochLear ADR shows a prevailing Real Value of $99.07 per share. The current price of the firm is $99.89. Our model approximates the value of CochLear ADR from analyzing the firm fundamentals such as return on equity of 0.17, and Profit Margin of 0.18 % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that CochLear's price fluctuation is very steady at this time. Calculation of the real value of CochLear ADR is based on 3 months time horizon. Increasing CochLear's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since CochLear is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CochLear Pink Sheet. However, CochLear's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 99.89 | Real 99.07 | Hype 99.89 | Naive 98.45 |
The intrinsic value of CochLear's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence CochLear's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of CochLear Ltd ADR helps investors to forecast how CochLear pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CochLear more accurately as focusing exclusively on CochLear's fundamentals will not take into account other important factors: CochLear Total Value Analysis
CochLear Ltd ADR is currently estimated to have takeover price of 9.05 B with market capitalization of 9.71 B, debt of 253.9 M, and cash on hands of 629.3 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the CochLear fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
9.05 B | 9.71 B | 253.9 M | 629.3 M |
CochLear Investor Information
The company last dividend was issued on the 21st of September 2022. Based on the analysis of CochLear's profitability, liquidity, and operating efficiency, CochLear Ltd ADR is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.CochLear Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CochLear has an asset utilization ratio of 66.87 percent. This suggests that the Company is making $0.67 for each dollar of assets. An increasing asset utilization means that CochLear Ltd ADR is more efficient with each dollar of assets it utilizes for everyday operations.CochLear Profitability Analysis
The company reported the revenue of 1.65 B. Net Income was 289.1 M with profit before overhead, payroll, taxes, and interest of 1.24 B.About CochLear Valuation
Our relative valuation model uses a comparative analysis of CochLear. We calculate exposure to CochLear's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CochLear's related companies.Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company was founded in 1981 and is headquartered in Sydney, Australia. Cochlear operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 4500 people.
8 Steps to conduct CochLear's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CochLear's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CochLear's valuation analysis, follow these 8 steps:- Gather financial information: Obtain CochLear's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CochLear's revenue streams: Identify CochLear's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CochLear's industry and market trends, including the size of the market, growth rate, and competition.
- Establish CochLear's growth potential: Evaluate CochLear's management, business model, and growth potential.
- Determine CochLear's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CochLear's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
CochLear Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 119.3 M | |
| Quarterly Earnings Growth Y O Y | 0.359 | |
| Forward Price Earnings | 46.0829 | |
| Retained Earnings | 455.3 M |
Additional Tools for CochLear Pink Sheet Analysis
When running CochLear's price analysis, check to measure CochLear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CochLear is operating at the current time. Most of CochLear's value examination focuses on studying past and present price action to predict the probability of CochLear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CochLear's price. Additionally, you may evaluate how the addition of CochLear to your portfolios can decrease your overall portfolio volatility.